These days there is a lot of talk about Diana, an acronym for Intelligent Diagnostics for Advanced Non-Invasive Analysis, a “medical cabinet” capable of carrying out over 60 tests in 15 minutes. But is it really like that? This is how the all-Italian technology works which promises a revolution in diagnostics
Home photovoltaic special: how to save with solar energy
Diana (Intelligent Diagnostics for Advanced Non-Invasive Analysis) is a “medical cabin” that promises to deliver over 60 exams in 15 minutes and was developed by Antares Vision GroupItalian multinational, e IsinnovaBrescia-based SME. It really could revolutionize diagnostics?
Let’s be cautious with announcements first of all because the first prototype will be ready at the end of June 2025 and will not be applied to everything, or everywhere, but the premises give rise to hope.
How Diana works
For the realization of this project we used technologies already known or in the experimental phase and we combined them, compacting them in the creation of Diana, thanks to the work of our team of experts – explain Cristian Fracassi and Marco Silvestri of Isinnova, CEO and project manager respectively Diana – The objective of the cabin, of which we would like to create multiple versions depending on the various branches of use, is not to replace the doctor, but speed up the work of healthcare professionals
In fact, like all investigative tools, it returns data that only an expert is able to interpret and evaluate. The cabin will in fact support you in the data collection phasespeeding up the process of acquiring and integrating information, which promises to be of high quality, even in centers less equipped than the well-known and ultra-specialised ones.
Diana’s first applications
The first prototype will be used at the National RNA & Genetherapy Center to monitor patients undergoing advanced gene and pharmacological therapieson which modern medicine relies heavily also for pathologies that are difficult to treat today, including some forms of cancer.
The potential of Diana combined with gene therapy protocols can help us monitor in real time the effectiveness of drugs with RNA technology which, as a national research centre, we are developing – says Rosario Rizzuto, President of the National Center for Therapy Development Foundation gene and drugs with RNA technology – Supporting a technology like Diana’s means shorten search times, simplify diagnostic stepsbut above all find increasingly precise and sustainable treatments
We are really looking forward to seeing Diana in action, but for the first results we will have to wait until second half of 2025.
